Fewer Bleeds Follow Move to Extended Half-life Therapy, Study Finds

Fewer Bleeds Follow Move to Extended Half-life Therapy, Study Finds

299812

Fewer Bleeds Follow Move to Extended Half-life Therapy, Study Finds

People with severe hemophilia A who switch from standard to extended half-life replacement therapies experience fewer bleeds and require less frequent infusions, an analysis of patients in Austria indicates. Whether these gains are reflected in lower overall treatment costs, however, is less clear, its researchers added. Data from this analysis were described in the study, “Bleeding outcomes and factor utilization after switching to an extended half-life product for prophylaxis in haemophilia A in Austria,” published…

You must be logged in to read/download the full post.